CA
CME icon

Clearstead Advisors’s CME Group CME Stock Holding History

Clearstead Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
16,037
+1,119
+8% +$310K 0.03% 293
2026
Q1 		$4.41M Sell
14,918
-213
-1% -$63.3K 0.04% 251
2025
Q4 		$4.13M Buy
15,131
+581
+4% +$158K 0.05% 229
2025
Q3 		$3.93M Sell
14,550
-121
-0.8% -$32.9K 0.05% 221
2025
Q2 		$4.04M Buy
14,671
+979
+7% +$266K 0.06% 217
2025
Q1 		$3.63M Buy
13,692
+295
+2% +$72.8K 0.06% 218
2024
Q4 		$3.11M Sell
13,397
-292
-2% -$67.1K 0.05% 234
2024
Q3 		$3.02M Buy
13,689
+209
+2% +$43.2K 0.05% 241
2024
Q2 		$2.65M Buy
13,480
+1,418
+12% +$293K 0.05% 243
2024
Q1 		$2.53M Buy
12,062
+517
+4% +$109K 0.13% 134
2023
Q4 		$2.43M Buy
11,545
+320
+3% +$68.3K 0.13% 134
2023
Q3 		$2.25M Buy
11,225
+176
+2% +$35K 0.14% 126
2023
Q2 		$2.05M Buy
11,049
+9,524
+625% +$1.76M 0.12% 141
2023
Q1 		$292K Buy
1,525
+1,035
+211% +$187K 0.02% 341
2022
Q4 		$82.4K Sell
490
-45
-8% -$7.82K 0.01% 536
2022
Q3 		$95K Buy
535
+24
+5% +$4.74K 0.01% 486
2022
Q2 		$105K Buy
511
+22
+4% +$4.66K 0.01% 494
2022
Q1 		$116K Buy
489
+483
+8,050% +$113K 0.01% 517
2021
Q4 		$1K Sell
6
-22
-79% -$4.84K ﹤0.01% 1164
2021
Q3 		$5K Buy
28
+5
+22% +$1.01K ﹤0.01% 1016
2021
Q2 		$5K Buy
+23
New +$4.86K ﹤0.01% 878
2020
Q4 		– Sell
-50
Closed -$8K – 985
2020
Q3 		$8K Buy
+50
New +$8.42K ﹤0.01% 690

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Clearstead Advisors's CME Position: Q2 2026 in Review

Clearstead Advisors increased its CME Group (CME) stake by 7.5% in Q2 2026, buying an estimated $310K and bringing the position to 16,037 shares worth $3.54M. The position accounts for 0.03% of the portfolio, ranked #293.

Clearstead Advisors first reported a position in CME in Q3 2020 and has held it in 22 quarters since. The position peaked at $4.41M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Clearstead Advisors held 16,037 shares of CME Group worth $3.54M as of Q2 2026.
  • Clearstead Advisors bought 1,119 CME Group shares in Q2 2026, an estimated $310K.
  • CME Group made up 0.03% of Clearstead Advisors's portfolio in Q2 2026, its #293 holding.
  • Clearstead Advisors first reported a position in CME Group in Q3 2020 and has held it in 22 quarters since.
  • Clearstead Advisors's CME Group position peaked at $4.41M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.